NIMH Code: | M-921 |
Compound Name: | (-)-4-(2-methoxyphenyl)-3,7,7-trimethyl-2H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-b]quinolin-5-one |
Alternative Name: | |
Abbreviation: | (-)-JB1121 |
PubChemID: | |
CAS: | 1597439-29-6 |
Molecular Formula: | C19H21N3O2 |
Biological Activity: | Serine/threonine kinase glycogen synthase kinase-3 (GSK3) inhibitor. |
References: | Wagner, F.F.; Pan, J.Q.; Dandapani, S.; Germain, A.; Holson, E.; Munoz, B.; Nag, P.P.; Weiwer, M.; Lewis, M.C.; Haggarty, S.J.; Bishop, J.A.; Stegmaier, K.; Banerji, V., 2014, Patent WO 2014059383. Scolnick, E.; Cottrell, J.R.; Wagner, F.F.; Holson, E.; Lewis, M.C.; Bear, M.F.; Stoppel, L.; Heynen, A., 2016, Patent US 20160375006. |
Comments: | CAS Number is for the racemate |
Last Updated 2021-03-03 09:13 AM |
Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.